Omkar Speciality Chemicals is currently trading at Rs. 158.80, up by 2.50 points or 1.60% from its previous closing of Rs. 156.30 on the BSE.
The scrip opened at Rs. 168.00 and has touched a high and low of Rs. 187.00 and Rs. 158.00 respectively. So far 79,000 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 187.00 on 04-Jun-2015 and a 52 week low of Rs. 114.50 on 13-Jun-2014.
Last one week high and low of the scrip stood at Rs. 187.00 and Rs. 153.10 respectively. The current market cap of the company is Rs. 326.00 crore.
The promoters holding in the company stood at 63.07% while Institutions and Non-Institutions held 14.48% and 22.45% respectively.
Omkar Speciality Chemicals has filed one more application for the grant of Patent for preparing 4-Bromo-Ortho-Phenylene-Diamine, a key precursor for making of the drug namely Ledipasvir. Ledipasvir is a drug for the treatment of Hepatitis C.
Omkar Speciality Chemicals (including its wholly owned subsidiaries) has 9 Units in the State of Maharashtra, India (5 Units in Badlapur, Dist: Thane, 3 Units in Chiplun, Dist: Ratnagiri and 1 Unit in Mahad, Dist: Raigad) with a total volumetric installed capacity of 4920 MTPA.
